Education
About Us
Working with TipRanks
Follow Us
Kontafarma China Holdings Ltd (HK:1312)
:1312
RESEARCH TOOLSreports
Total Valuation
Kontafarma China Holdings Ltd has a market cap or net worth of HK$161.78M. The enterprise value is ―.
Market CapHK$161.78M
Enterprise Value―
Share Statistics
Kontafarma China Holdings Ltd has 5,588,572,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,588,572,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kontafarma China Holdings Ltd’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee1.13M
Profits Per Employee-61.51K
Employee Count714
Asset Turnover0.47
Inventory Turnover3.44
Valuation Ratios
The current PE Ratio of Kontafarma China Holdings Ltd is -6.96. Kontafarma China Holdings Ltd’s PEG ratio is 0.02.
PE Ratio-6.96
PS Ratio0.00
PB Ratio0.14
Price to Fair Value0.19
Price to FCF2.55
Price to Operating Cash Flow2.01
PEG Ratio0.02
Income Statement
In the last 12 months, Kontafarma China Holdings Ltd had revenue of 809.11M and earned -28.84M in profits. Earnings per share was -0.01.
Revenue809.11M
Gross Profit471.29M
Operating Income0.00
Pretax Income-43.92M
Net Income-28.84M
EBITDA76.63M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was 89.75M and capital expenditures -18.83M, giving a free cash flow of 70.92M billion.
Operating Cash Flow89.75M
Free Cash Flow70.92M
Free Cash Flow per Share0.01
Dividends & Yields
Kontafarma China Holdings Ltd pays an annual dividend of HK$0.003, resulting in a dividend yield of ―
Dividend Per ShareHK$0.003
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.17
52-Week Price Change-25.00%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)57.78
Average Volume (3m)449.20K
Important Dates
Kontafarma China Holdings Ltd upcoming earnings date is Sep 1, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateSep 1, 2025
Ex-Dividend DateMay 27, 2013
Financial Position
Kontafarma China Holdings Ltd as a current ratio of 1.53, with Debt / Equity ratio of 26.75%
Current Ratio1.53
Quick Ratio1.28
Debt to Market Cap0.26
Net Debt to EBITDA3.34
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Kontafarma China Holdings Ltd has paid 17.20M in taxes.
Income Tax17.20M
Effective Tax Rate-0.39
Enterprise Valuation
Kontafarma China Holdings Ltd EV to EBITDA ratio is 5.96, with an EV/FCF ratio of 35.36.
EV to Sales0.56
EV to EBITDA5.96
EV to Free Cash Flow35.36
EV to Operating Cash Flow12.31
Balance Sheet
Kontafarma China Holdings Ltd has HK$78.66M in cash and marketable securities with HK$284.64M in debt, giving a net cash position of HK$205.98M billion.
Cash & Marketable SecuritiesHK$78.66M
Total DebtHK$284.64M
Net CashHK$205.98M
Net Cash Per ShareHK$0.04
Tangible Book Value Per ShareHK$0.10
Margins
Gross margin is 59.10%, with operating margin of 0.00%, and net profit margin of -3.56%.
Gross Margin59.10%
Operating Margin0.00%
Pretax Margin-5.43%
Net Profit Margin-3.56%
EBITDA Margin9.47%
EBIT Margin-3.54%
Analyst Forecast
The average price target for Kontafarma China Holdings Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast10.93%
EPS Growth Forecast-159.62%